(Q46352552)

21 December 2017

reason for preferred rank

title

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody (English)

1 reference

https://api.crossref.org/works/10.1038/355728A0

13 November 2022

Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody (English)

1 reference

PubMed ID

1741059

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1741059

13 November 2022

main subject

prevention of HIV/AIDS

0 references

1 reference

1 reference

1 reference

Emini EA

1

1 reference

21 December 2017

Schleif WA

2

1 reference

21 December 2017

Nunberg JH

3

1 reference

21 December 2017

Conley AJ

4

1 reference

21 December 2017

Eda Y

5

1 reference

21 December 2017

Tokiyoshi S

6

1 reference

21 December 2017

Putney SD

7

1 reference

21 December 2017

Matsushita S

8

1 reference

21 December 2017

Cobb KE

9

1 reference

21 December 2017

Jett CM

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 February 1992

1 reference

21 December 2017

20 February 1992

1 reference

National Center for Biotechnology Information

PubMed ID

1741059

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1741059

13 November 2022

number of pages

3

1 reference

full work available at URL

inferred from page(s)

http://www.nature.com/articles/355728a0

1 reference

https://api.crossref.org/works/10.1038/355728A0

http://www.nature.com/articles/355728a0.pdf

13 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/355728A0

13 November 2022

1 reference

21 December 2017

volume

355

1 reference

21 December 2017

page(s)

728-730

1 reference

21 December 2017

issue

6362

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/355728a0

exact match

0 references

cites work

Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts

1 reference

7 January 2021

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1 reference

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

7 January 2021

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

1 reference

7 January 2021

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

7 January 2021

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

1 reference

7 January 2021

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

7 January 2021

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

7 January 2021

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

1 reference

7 January 2021

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

1 reference

7 January 2021

A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity

1 reference

7 January 2021

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

1 reference

7 January 2021

Identifiers

DOI

10.1038/355728A0

1 reference

21 December 2017

Dimensions Publication ID

0 references

1 reference

21 December 2017